Prevention of gestational diabetes mellitus: Where are we now?

被引:37
|
作者
Simmons, D. [1 ]
机构
[1] Univ Western Sydney, Macarthur Clin Sch, Campbelltown, NSW 2560, Australia
来源
DIABETES OBESITY & METABOLISM | 2015年 / 17卷 / 09期
关键词
gestational diabetes; glucose tolerance test; lifestyle; metformin; myoinositol; nutrition; physical activity; prevention; probiotic; vitamin D; LIFE-STYLE INTERVENTION; RANDOMIZED CONTROLLED-TRIAL; POLYCYSTIC-OVARY-SYNDROME; EXCESSIVE WEIGHT-GAIN; OBESE PREGNANT-WOMEN; HIGH-RISK; MYOINOSITOL SUPPLEMENTATION; PHYSICAL-ACTIVITY; VITAMIN-D; GLUCOSE-METABOLISM;
D O I
10.1111/dom.12495
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gestational diabetes mellitus (GDM) is increasing at a rapid rate, driven by the increasing proportion of the population that is overweight/obese from a young age. More than 25 randomized controlled trials testing whether GDM can be prevented have now reported their findings, but only four different interventions have shown a reduction in the proportion of women with GDM (healthy eating alone, healthy eating with physical activity, myoinositol supplementation and probiotic treatment), and these results have not been replicated. The interventions tested to date include different diets and different forms of physical activity, in combination or alone, vitamin D, myoinositol, probiotics and metformin. Studies could be improved by using the International Association of Diabetes and Pregnancy Study Group criteria for GDM (which are probably more sensitive to change because of their multiple time points), targeting and tailoring interventions to subgroups most likely to benefit, and separating those with GDM early in pregnancy from those developing GDMde novo. The greatest societal benefit is likely to arise from population-based lifestyle approaches which include those women yet to become pregnant and those who are already pregnant and their families; an approach that is yet to be fully tested.
引用
收藏
页码:824 / 834
页数:11
相关论文
共 50 条
  • [1] Gestational diabetes mellitus: Where are we now?
    Ashwal, Eran
    Hod, Moshe
    CLINICA CHIMICA ACTA, 2015, 451 : 14 - 20
  • [2] Postnatal Prevention of Childhood Obesity in Offspring Prenatally Exposed to Gestational Diabetes mellitus: Where Are We Now?
    Dugas, Camille
    Perron, Julie
    Kearney, Michele
    Mercier, Roxanne
    Tchernof, Andre
    Marc, Isabelle
    Weisnagel, S. John
    Robitaille, Julie
    OBESITY FACTS, 2017, 10 (04) : 396 - 406
  • [3] PREVENTION OF GESTATIONAL DIABETES MELLITUS (GDM): WHERE WE STAND AND WHERE TO GO?
    Samuel, Tinu Mary
    Spieldenner, Jorg
    Zolezzi, Silva Irma
    ANNALS OF NUTRITION AND METABOLISM, 2017, 71 : 972 - 972
  • [4] Prevention of insulin-dependent diabetes: Where are we now?
    Pozzilli, P
    DIABETES-METABOLISM REVIEWS, 1996, 12 (02): : 127 - 135
  • [5] Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand
    Rani, P. Reddi
    Begum, Jasmina
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (04) : QE1 - QE4
  • [6] Prevention of gestational diabetes: where do we go from here?
    Scifres, C.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 127 (13) : 1617 - 1617
  • [7] Editorial: Gestational diabetes: where are we and where are we going?
    Piani, Federica
    Tossetta, Giovanni
    FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE, 2024, 5
  • [8] Microbiome and diabetes: Where are we now?
    Vallianou, Natalia G.
    Stratigou, Theodora
    Tsagarakis, Stylianos
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 146 : 111 - 118
  • [9] HIV prevention 2010: where are we now and where are we going?
    Cohen, Myron S.
    Fidler, Sarah
    CURRENT OPINION IN HIV AND AIDS, 2010, 5 (04) : 265 - 268
  • [10] Prevention of Ovarian Cancer: Where are We Now and Where are We Going?
    Rodriguez, Isabel V.
    Ghezelayagh, Talayeh
    Pennington, Kathryn P.
    Norquist, Barbara M.
    CURRENT ONCOLOGY REPORTS, 2024, 26 (11) : 1355 - 1366